African journal of paediatric surgery : AJPS
-
Afr J Paediatr Surg · Sep 2012
Comparative StudyRecombinant-activated factor VII in the paediatric cardiac surgery: single unit experience.
The control of excessive bleeding after paediatric cardiac surgery can be challenging. This may make the use of recombinant-activated factor VII (rFVIIa) in preventing this excessive bleeding, after adopted conventional methods have failed, desirable. Our aim is to highlight our experience with the use of rFVIIa in preventing excessive bleeding after paediatric cardiac surgery. ⋯ rFVIIa use is not only effective in stopping excessive perioperative bleeding but also safe and indirectly reduces transfusion of blood and its products.